Gastric epithelial cell proliferation and apoptosis in Helicobacter pylori-infected mice

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 1, 2000, Pages 68-73

  Yamaguchi, T ^a   Nakajima, N ^a   Kuwayama, H ^b   Ito, Y ^a   Iwasaki, A ^a   Arakawa, Y ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BACTERIAL INFECTION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; GASTRITIS; GASTRODUODENAL ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HELICOBACTER PYLORI INFECTION; HISTOCHEMISTRY; INTESTINE INFECTION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; STOMACH EPITHELIUM;

EID: 0034031817     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.014s1068.x     Document Type: Conference Paper

References (45)

1. Parsonnet J, Friedman G, Vanderxsteen D, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
2. Cover TL, Blaser MJ. Helicobacler pylori and gastroduodenal disease. Annu Rev Med 1992; 43: 135-45.
3. Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-9.
4. Hansson LE, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
5. Forman D. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
6. World Health Organization. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs Evaluation Carcinogenic Risks Humans. Lyon, France: International Agency for Research on Cancer 1994; 61: 177-240.
7. Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995; 36: 346-50.
8. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88: 1870-5.
9. Cahill RJ, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994; 6: 1123-7.
10. Cahill RJ, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Gastic epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996; 38: 177-81.
11. Correa P. A human model of gastric carcinogenesis. Cancer Res 1989; 48: 3554-60.
12. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Torok LA, Mullauer L. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett 1995; 82: 143-8.
13. Vayx D, StrasSeries A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 109: 2239-44.
14. Kerr JFR, Winterford CBVH. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
15. Ben-Sasson S, Sherman Y, Gavrielli Y. Identification of dying cells: in situ staining. Meth Cell Biol 1995; 46: 29-39.
16. Hall P, Coates P, Ansari A, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-77.
17. Moss S, Calam J, Agarwal B, Wang S, Holt P. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
18. Mannick E, Bravo L, Zarama G, Wang S, Holt P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56: 3238-43.
19. Tummuru M, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61: 1799-809.
20. Rauws E, Langenberg W, Houthoff H, Zanen H, Tytgat G. Campylobacter pyloridis associated chronic active antral gastrtis. Gastroenterology 1988; 94: 33-40.
21. National Institutes of Health Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
22. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 1996; 41: 85-117.
23. Fox J, Correa P, Taylor N, et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 1989; 84: 775-81.
24. Sasaki N, Momma K, Yamada Y, et al. Helicobacter pylori and early gastric cancer: relation to atrophic gastritis in background gastric mucosa. Eur J Gastroenterol 1993; 5: S123-6.
25. Sipponen P, Kekki M, Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer 1984; 49: 521-30.
26. Kuiper E, Uyterlinde A, Pena A, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-8.
27. Fujiyama K, Fujioka T, Murakami K, et al. Effects of Helicobacter pylori infection on gastric mucosal defense factors in Japanese monkeys. J Gastroenterol 1995; 30: 441-6.
28. Fujioka K, Shuto R, Kodama R, et al. Experimental model for chronic gastritis with Helicobacter pylori: long-term follow-up study in H. pylori-infected Japanese macaques. Eur J Gastroenterol Hepatol 1993; 5(Suppl. 1): S73-S77.
29. Honda S, Fujioka T, Tokieda T, et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-9.
30. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
31. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1-15.
32. Que F, Gores G. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996; 110: 1238-43.
33. Nakajima N, Kuwayama H, Iwasaki A, Arakawa Y. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial growth. J Clin Gastroenterol 1995; 20(Suppl. 2): S90-2.
34. Knipp U, Birkholz S, Kaup W, Opferhuch W. Partial characterization of a cell proliferation-inhibiting protein induced by Helicobacter pylori. Infect Immun 1996; 64: 3491-6.
35. Ricci V, Ciacci C, Zarrilli R, et al. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun 1996; 64: 2929-33.
36. Wagner S, Beil W, Westermann J, et al. Regulation of gastric-epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997; 113: 1836-47.
37. Romano M, Ricci V, Popolo A, et al. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest 1998; 101: 1604-13.
38. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102: 720-7.
39. Blaser MJ, Parsonnet J. Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8.
40. Lee A, Fox J, Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun 1993; 61: 1601-10.
41. Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151: 1695-703.
42. Tsujii M, Kawano S, Tsuji S, et al. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology 1992; 102: 1881-1888.
43. Kawano S, Tsujii M, Fusamoto H, et al. Chronic effect of intragastric ammonia on gastric mucosal stracture in rats. Dig Dis Sci 1991; 36: 33-8.
44. Tsujii M, Kawano S, Tsuji S, et al. Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia. Gastroenterology 1993; 104: 796-801.
45. Konturek P, Bobrzynski A, Konturek S, et al. Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication. Scand J Gastroenterol 1998; 33: 143-51.